The company was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 (Partnership Act) in the name and style of Sotac Pharmaceuticals, pursuant to a deed of partnership dated December 10, 2014. Thereafter Sotac Pharmaceuticals was converted from Partnership Firm to a Private Limited Company under Part I (Chapter XXI) of the Companies Act, 2013 in the name of Sotac Pharmaceuticals Private Limited and received a certificate of incorporation dated December 18, 2015 from the Assistant Registrar of Companies, Gujarat. Later on the company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of the Company held on November 12, 2022 and the name of the Company was changed to Sotac Pharmaceuticals Limited. A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated November 22, 2022 was issued by the Registrar of Companies, Ahmedabad.

Sotac Pharmaceuticals is in business of manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. Its business is majorly on principle to principle basis with different marketers. The company caters to corporate clients on loan licence and/or contract manufacturing basis. The company has commenced manufacturing facility in year 2017, hence, the company has experience of more than 5 years in the current line of business of the company. In year 2017, the company’s manufacturing facility was installed with capacity to manufacture 90 crore tables / year, 14 crore Capsules / year.

Business area of the company

The company specializes in the production of high-quality pharmaceutical products on a loan license or contract manufacturing basis. It has a diverse product portfolio that includes a wide range of pharmaceuticals, nutraceuticals, and food products.

Key Events/Milestone/ Achievement

• 2015: The company was incorporated as a private limited company under the name Sotac Pharmaceuticals Private Limited.
  
• 2019: Recognised as ‘Fastest Growing Indian Company’ with and Excellence Award by International Achievers Conference.
  
• 2021: Received ‘Indo Global award for Business Excellence’ 2022.
  
• 2022: The Company has acquired 53,25,000 Equity Shares in SOTAC Healthcare Private Limited making it subsidiary of the Company.
  
• 2022: The Company has acquired 99,995 Equity Shares in SOTAC Research Private Limited making it wholly owned subsidiary of the Company.
  
• 2022: The Company was converted into Public Limited Company under the name of ‘Sotac Pharmaceuticals Limited’.
  
• 2022: Received recognition as for ‘Fastest Expansion of Project’ by Sanand Industries Association (SIA).
  
• 2022: Recognized as one of the ‘Top 10 Pharma Contract Manufacturers in India’ by India Pharma Outlook.